A recent study15 revealed a novel drug resistance mechanism in which drug-sensitive cancer cells secrete various soluble factors (e.g., IGF and HGF) into the tumor microenvironment in response to targeted therapy. The gene discussed is IGF1; the disease is neoplasm.